{
  "pmcid": "12365548",
  "sha256": "aac5f5845c6f9d29470ec694a62a35e53fe0289d15f71054ee23ee8648d3d597",
  "timestamp_utc": "2025-11-09T23:34:30.084790+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.32734991423671,
    "reading_ease": 35.30546740994856,
    "word_count": 265
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of No-Touch Saphenous Vein Grafts in Coronary Artery Bypass Grafting"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomisation was performed using a computer-generated sequence"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were patients undergoing CABG, with eligibility criteria including suitability for SV grafting. The study was conducted at multiple centers."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received NT SV grafts, while the control group received conventionally harvested SV grafts."
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial aimed to compare the patency rates of NT SV grafts with conventionally harvested SV grafts."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was graft patency, assessed at 12 months postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 2655 patients were randomised, with 1328 in the NT group and 1327 in the control group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on 1300 NT and 1295 control patients using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The NT group showed a significantly lower occlusion rate (3.7%) compared to the control group (6.5%), with an odds ratio of 0.56 (95% CI, 0.41â€“0.76; P <0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Leg wound complications were reported in 1.3% of NT patients."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: N/A."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}